7697.5000 144.50 (1.91%)
NSE Apr 17, 2026 13:46 PM
Volume: 220.7K
 

7697.50
1.91%
Prabhudas Lilladhar
to ensure non-compete and synergy alignment between AHEL and NewCo, with clear role demarcation - AHEL to focus on core healthcare and NewCo on pharmacy & digital. The demerger was on expected lines and is aimed to unlock value by creating a focused, high-growth platform in the pharmacy and digital healthcare space, which is more consumer centric in nature. The stake sale in HealthCo to Advent and merger with Keimed are a positive step and will lead to an integrated pharmacy distribution business. Scale-up in...
Apollo Hospitals Ent.. has an average target of 8655.33 from 6 brokers.
More from Apollo Hospitals Enterprise Ltd.
Recommended